India’s indigenous vaccine against cervical cancer is expected to be a low-cost, affordable vaccine and to be useful for nearly 50 million girls aged 9–14 years. Read More
India’s indigenous vaccine against cervical cancer is expected to be a low-cost, affordable vaccine and to be useful for nearly 50 million girls aged 9–14 years.